Systematic evolution of ligands by exponential enrichment: blended SELEX
AssigneeGilead Sciences, Inc.
InventorsGreg Biesecker, Sumedha D. Jayasena, Larry Gold, Drew Smith, Gary P. Kirschenheuter
Life of this patent
Estimating the term…
Loading patent…
AssigneeGilead Sciences, Inc.
InventorsGreg Biesecker, Sumedha D. Jayasena, Larry Gold, Drew Smith, Gary P. Kirschenheuter
Estimating the term…
A method is described for generating blended nucleic acid ligands containing non-nucleic acid functional units. Specifically, a SELEX identified RNA ligand to the integrin gpIIbIIIa is conjugated to the peptide Gly-Arg-Gly-Asp-Thr-Pro (SEQ ID NO: 1). This blended RNA ligand inhibits the biological activity of gpIIbIIIa with high specificity. Also described is a single-stranded DNA ligand to elastase coupled to N-methoxysuccinyl-Ala-Ala-Pro-Val-chloromethyl ketone (SEQ ID NO: 2). This elastase blended nucleic acid ligand inhibits the biological activity of elastase.
A blended nucleic acid ligand of a target compound prepared by a method comprising the steps of:
A diagnostic reagent comprising a blended nucleic acid ligand of a target compound and a reporter molecule, wherein said diagnostic reagent is prepared by a method comprising the steps of:
Dependencies are inferred from the claim text.